1-3 of 3
Stefan Söderhäll
Close
Sort by
Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)

C. Michel Zwaan, MD PhD, Stefan Söderhäll, MD PhD, Benoit Brethon, MD, Matteo Luciani, MD, Carmelo Rizzari, MD, David Sternberg, MD PhD, Emmanuelle Besse, Catherine Dutreix, MD, Franca Fagioli, MD, Phoenix Ho, MD, Carlo Dufour, MD, Rob Pieters, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2564.
https://doi.org/10.1182/blood.V126.23.2564.2564
Published: 2015
Journal Articles

DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia

Lili Milani, Anders Lundmark, Anna Kiialainen, Jessica Nordlund, Trond Flaegstad, Erik Forestier, Mats Heyman, Gudmundur Jonmundsson, Jukka Kanerva, Kjeld Schmiegelow, Stefan Söderhäll, Mats G. Gustafsson, Gudmar Lönnerholm, Ann-Christine Syvänen
Journal: Blood
Blood (2010) 115 (6): 1214–1225.
https://doi.org/10.1182/blood-2009-04-214668
Published: 2010
Includes: Supplemental data
Journal Articles

Treatment Outcome of Children over 10 Years and Young Adults with ALL in Sweden: A Comparison between Paediatric- and Adult Protocols.

Mats Heyman, MD, PhD, Goran Gustafsson, MD, PhD, Bengt Smedmyr, MD, PhD, Stefan Soderhall, MD, PhD, Helene Hallbook, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 8.
https://doi.org/10.1182/blood.V106.11.8.8
Published: 2005